18F-Fluorodeoxyglucose (FDG) PET for Measurement of Response and Prediction of Outcome to Relapsed/Refractory Mantle Cell Lymphoma (MCL) Therapy with Bendamustine-Rituximab(BR)
Lamonica, D., Graf, D. A., Munteanu, M. C., Czuczman, M. S.Language:
english
Journal:
Journal of Nuclear Medicine
DOI:
10.2967/jnumed.116.173542
Date:
July, 2016
File:
PDF, 742 KB
english, 2016